medigraphic.com

2012, Number S2

Rev Mex Anest 2012; 35 (S2)

Guía de práctica clínica para el manejo de la anestesia regional en el paciente que recibe anticoagulación y tromboprofilaxis

Carrillo ER, Zaragoza LG, Covarrubias GA, Genis RMÁ, Guadarrama BV, Luna OP, Marrón PM, Mejía TGE, Moyao GD, Sosa GJO, Páez SF, Ramírez SEH, Rivera FJ, Silva BL, Tenopala VS, Reyes ZN, Aldrete VJ

Language: Spanish
References: 159
Page: 390-424
PDF size: 259.81 Kb.


ABSTRACT

Our objective was to develop clinical guidelines based on the best clinical evidence to help the medical staff of all levels (first, second and third medical attention levels) to provide evidence-based medicine and the management of regional anesthesia in patients receiving anticoagulation and thromboprophylaxis. The guidelines were built using structured and relevant clinical questions. We established a standardized sequence to search for clinical practice guidelines from questions on regional anesthesia treatment in patients receiving anticoagulation and thromboprophylaxis in children and adults. It was used as base document the clinical practice guideline based on evidence for patient treatment receiving anticoagulation and thromboprophylaxis published in 2009.The working group selected 37 publications. For aspects not considered in the reference guides, structured researches using PubMed, Medical Disability Advisor and Cochrane Library publish were done. The results were expressed according as level of evidence and grade of recommendation according to the characteristics and type of study design. A priority is to properly manage the patient requires a procedure for receiving regional anesthesia and coagulation-modifying drugs. The specialist should know the evidence-based recommendations for the proper management of these patients.


REFERENCES

  1. Levy JH, Key NS, Azran MS. Novel oral anticoagulants. Implications in the perioperative setting. Anesthesiology 2010;113:726-45.

  2. Allen DJ, Chae-Kim SH, Trousdale DM. Risks and complications of neuraxial anesthesia and the use of anticoagulation in the surgical patient. Proc (Bayl Univ Med Cent) 2002;15:369-373.

  3. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172-197.

  4. Guía de práctica clínica basada en la evidencia para el manejo de anestesia regional y anticoagulación. Rev Mex Anest 2009;32:S247-S276.

  5. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.

  6. Brinkhous KM. Smith HP, Warner E, et al. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Am J Physiol 1939;125:683-687.

  7. Hirsch J, Anand S, Fuster V. Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 2001;21:1094-1196.

  8. Hirsch J, Raschke R. Heparin and low-molecular-weight heparin: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:188-203.

  9. Pravinkumar E, Webster NR. HIT/HITT and alternative anticoagulation: current concepts. Br J Anaesth 2003;90:676-685.

  10. Hardman J, Joel G, Limbird L y cols. Goodman & Guilman. Las bases farmacológicas de la terapéutica. 10ª ed. México, D.F McGraw-Hill/Interamericana; 2003:1547-1550.

  11. Llau J, Andrés J, Gomaret C y cols. Fármacos que alteran la hemostasia y técnicas regionales anestésicas y analgésicas: recomendaciones de seguridad (foro de consenso). Rev Soc Esp Dolor 2001;8:337-348.

  12. Kopp, Horlocker S. Anticoagulation in pregnancy and neuroaxial blocks. Anesthesiology Clin 2008;26:1-22.

  13. Lee C. Epidural hematomas in the setting of regional anesthesia: Diagnosis, treatment, and prevention. Seminars in Anesthesia, Perioperative Medicine and Pain 2003;22:209-217.

  14. Rainer J, Gottschlich B, Stehr S. Spinal epidural hematoma after spinal anesthesia in a patient treated with clopidogrel and enoxaparin. Anesthesiology 2004;101:1467-1470.

  15. Chan L, Bailin M. Spinal epidural hematoma following central neuraxial blockade and subcutaneous enoxaparin: A case report. J Clin Anesth 2004;16:382-385.

  16. Cullen D, Bogdanov E, Htut N. Spinal epidural hematoma occurrence in the absence of known risk factors: A case series. J Clin Anesth 2004;16:376-381.

  17. Cywinski J, Parker B, Lozada L. Spontaneous spinal epidural hematoma in a pregnant patient. J Clin Anesth 2004;16:371-375.

  18. Horlocker T, Wedel D, Rowlingson J. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy American Society of Regional Anesthesia and Pain Medicine Evidence-based Guidelines (third edition). Regional Anesthesia and Pain Medicine 2010;35:64-101.

  19. Vandermeulen E, Van Aken H, Vermylen J. Anticoagulant and spinal-epidural anesthesia. Anesthesiology 1994;79:1165-1177.

  20. Lumpkin M. Reports of epidural or spinal hematomas with the concurrent of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture. FDA Public Health Advisory 12. US Department of Health and Human Resources. Available in: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/default.html

  21. Horlocker T, Heit J. Low molecular weight heparin. Biochemistry, pharmacology, perioperative prophylaxis regimens and guidelines for regional anesthetic management. Anesth Analg 1997;85:874-885.

  22. Rodi Z, Štraus I, Deniæ K, et al. Case report: Transient paraplegia revealed by intraoperative neurophysiological monitoring: Was it caused by the epidural anesthetic or an epidural hematoma? Anesth Analg 2003;96:1785-1788.

  23. Lee L, Posner K, Domino K, et al. Injuries associated with regional anesthesia in the 1980s and 1990s. Anesthesiology 2004;101:143-152.

  24. Harbury O, Provenzale J, Barboriak D. Vertex epidural hematomas: imaging findings and diagnostic pitfalls. Eur J Radiol 2000;36:150-157.

  25. Sternlo JE, Hybbinette CH. Spinal subdural bleeding after attempted epidural and subsequent spinal anesthesia in a patient thrombo-prophylaxis with low molecular weight heparin. Acta Anaesthesiol Scand 1995;39:557-559.

  26. Server A, Tollesson G, Solgaad T, et al. Vertex epidural hematoma neuroradiologic findings and management. Acta Radiol 2002;43:483-485.

  27. Litz RJ, Hubler M, Koch T, et al. Spinal-epidural hematoma following epidural anesthesia in the presence of antiplatelet and heparin therapy. Anesthesiology 2001;95:1031-1033.

  28. Inoue K, Yokoyama M, Nakatsuka H, et al. Spontaneous resolution of epidural hematoma after continuous epidural analgesia in a patient without bleeding tendency. Anesthesiology 2002;97:735-737.

  29. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004;101:950-959.

  30. American College of Chest Physicians. Antithrombotic therapy and prevention of thrombosis. 9th ed: Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e737S-e801S.

  31. Samama CM, Albaladejo P, Bemhamou D, et al. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesthesiol 2006;23:95-116.

  32. De Pietri L, Siniscalchi A, Reggiani A, et al. The use of intrathecal morphine for postoperative pain relief after liver resection: a comparison with epidural analgesia. Anesth Analg 2006;102:1157-1163.

  33. Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010;27:999-1015.

  34. Chelly JE. The most recent recommendations for deep blocks and thromboprophylaxis evidence not supporting a thromboprophylaxis therapeutic window. Reg Anesth Pain Med 2010;35:402.

  35. Llau J, Ferrandis R. New anticoagulants and regional anesthesia. Current Opinion in Anaesthesiology 2009;22:661-666.

  36. Parvaiz M, Korwar V, McArthur D, et al. Large retroperitoneal haematoma: an unexpected complication of ilioinguinal nerve block for inguinal hernia repair. Anaesthesia 2012;67:73-84.

  37. Rodriguez J, Taboada M, Garcia F, et al. Intraneural hematoma after nerve stimulation guided femoral block in a patient with factor XI deficiency case report. Journal of Clinical Anesthesia 2011;23:234-237.

  38. Aida S, Takahashi H, Shimoji K. Renal subcapsular hematoma after lumbar plexus block. Anesthesiology 1996;84:452-455.

  39. Aveline C, Bonnet F. Delayed retroperitoneal haematoma after failed lumbar plexus block. Br J Anaesth 2004;93:589-591.

  40. Bickler P, Brandes J, Lee M, et al. Bleeding complications from femoral and sciatic nerve catheters in patients receiving low molecular weight heparin. Anesth Analg 2006;103:1036-1037.

  41. Klein SM, D’Ercole F, Greengrass RA, et al. Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumbar plexus block. Anesthesiology 1997;87:1576-1579.

  42. Nielsen CH. Bleeding after intercostal nerve block in a patient anticoagulated with heparin. Anesthesiology 1989;71:162-164.

  43. Wiegel M, Gottschaldt U, Hennebach R, et al. Complications and adverse effects associated with continuous peripheral nerve blocks in orthopedic patients. Anesth Analg 2007;104:1578-1582.

  44. Klassen GA, Bramwell RS, Bromage PR, et al. Effect of acute sympathectomy by epidural anesthesia on the canine coronary circulation. Anesthesiology 1980;52:8-15.

  45. Flatley KA, DeFily DV, Thomas JX Jr. Effects of cardiac sympathetic nerve stimulation during adrenergic blockade on infarct size in anesthetized dogs. J Cardiovasc Pharmacol 1985;7:673-679.

  46. Davis RF, DeBoer LW, Maroko PR. Thoracic epidural anesthesia reduces myocardial infarct size after coronary artery occlusion in dogs. Anesth Analg 1986;65:711-717.

  47. Blomberg S, Ricksten SE. Thoracic epidural anaesthesia decreases the incidence of ventricular arrhythmias during acute myocardial ischemia in the anaesthetized rat. Acta Anaesthesiol Scand 1988;32:173-178.

  48. Rolf N, Van de Velde M, Wouters PF, et al. Thoracic epidural anesthesia improves functional recovery from myocardial stunning in conscious dogs. Anesth Analg 1996;83:935-940.

  49. Scott NB, Turfrey DJ, Ray DA, et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 2001;93:528-535.

  50. Ho SC, Royse CF, Royse AG, et al. Persistent pain after cardiac surgery: an audit of high thoracic epidural and primary opioid analgesia therapies. Anesth Analg 2002;95:820-823.

  51. Stenseth R, Bjella L, Berg EM, et al. Thoracic epidural analgesia in aortocoronary bypass surgery. II: Effects on the endocrine metabolic response. Acta Anaesthesiol Scand 1994;38:834-839.

  52. Liem TH, Booij LH, Gielen MJ, et al. Coronary artery bypass grafting using two different anesthetic techniques: Part 3: Adrenergic responses. J Cardiothorac Vasc Anesth 1992;6:162-167.

  53. Kirno K, Friberg P, Grzegorczyk A, et al. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg 1994;79:1075-1081.

  54. Williams J. Thoracic epidural anesthesia for cardiac surgery. Can J Anesth 2002;49:7R.

  55. Loick HM, Schmidt C, Van Aken H, et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg 1999;88:701-709.

  56. Olausson K, Magnusdottir H, Lurje L, et al. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Circulation 1997;96:2178-2182.

  57. Stenseth R, Berg EM, Bjella L, et al. Effects of thoracic epidural analgesia on coronary hemodynamics and myocardial metabolism in coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1995;9:503-509.

  58. Blomberg S, Emanuelsson H, Ricksten SE. Thoracic epidural anesthesia and central hemodynamics in patients with unstable angina pectoris. Anesth Analg 1989;69:558-562.

  59. Kock M, Blomberg S, Emanuelsson H, et al. Thoracic epidural anesthesia improves global and regional left ventricular function during stress-induced myocardial ischemia in patients with coronary artery disease. Anesth Analg 1990;71:625-630.

  60. Blomberg S, Emanuelsson H, Kvist H, et al. Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anesthesiology 1990;73:840-847.

  61. Liem TH, Hasenbos MA, Booij LH, et al. Coronary artery bypass grafting using two different anesthetic techniques: Part 2: Postoperative outcome. J Cardiothorac Vasc Anesth 1992;6:156-161.

  62. Visser WA, Liem TH, Brouwer RM. High thoracic epidural anesthesia for coronary artery bypass graft surgery in a patient with severe obstructive lung disease. J Cardiothorac Vasc Anesth 2001;15:758-760.

  63. Tenling A, Joachimsson PO, Tyden H, et al. Thoracic epidural analgesia as an adjunct to general anaesthesia for cardiac surgery. Effects on pulmonary mechanics. Acta Anaesthesiol Scand 2000;44:1071-1076.

  64. Stenseth R, Bjella L, Berg EM, et al. Effects of thoracic epidural analgesia on pulmonary function after coronary artery bypass surgery. Eur J Cardiothorac Surg 1996;10:859-866.

  65. Moore CM, Cross MH, Desborough JP, et al. Hormonal effects of thoracic extradural analgesia for cardiac surgery. Br J Anaesth 1995;75:387-393.

  66. Stenseth R, Bjella L, Berg EM, et al. Thoracic epidural analgesia in aortocoronary bypass surgery: I. Hemodynamic effects. Acta Anaesthesiol Scand 1994;38:826-833.

  67. Kirno K, Friberg P, Grzegorczyk A, et al. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg 1994;79:1075-1081.

  68. Hoar PF, Hickey RF, Ullyot DJ. Systemic hypertension following myocardial revascularization: a method of treatment using epidural anesthesia. J Thorac Cardiovasc Surg 1976;71:859-864.

  69. Shayevitz JR, Merkel S, O’Kelly SW, et al. Lumbar epidural morphine infusions for children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1996;10:217-224.

  70. El-Baz N, Goldin M. Continuous epidural infusion of morphine for pain relief after cardiac operations. J Thorac Cardiovasc Surg 1987;93:878-883.

  71. Joachimsson PO, Nystrom SO, Tyden H. Early extubation after coronary artery surgery in efficiently rewarmed patients: a postoperative comparison of opioid anesthesia versus inhalational anesthesia and thoracic epidural analgesia. J Cardiothorac Anesth 1989;3:444-454.

  72. Robinson RJS, Brister S, Jones E, et al. Epidural meperidine analgesia after cardiac surgery. Can Anaesth Soc J 1986;33:550-555.

  73. Loick HM, Schmidt C, Van Aken H, et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg 1999;88:701-709.

  74. Birkett DA, Apthorp GH, Chamberlain DA, et al. Bilateral upper thoracic sympathectomy in angina pectoris: results in 52 cases. Br Med J 1965;2:187-190.

  75. Sanchez R, Nygard E. Epidural anesthesia in cardiac surgery: is there an increased risk? J Cardiothorac Vasc Anesth 1998;12:170-173.

  76. Hammer GB, Ngo K, Macario A. A retrospective examination of regional plus general anesthesia in children undergoing open heartsurgery. Anesth Analg 2000;90:1020-1024.

  77. Peterson KL, DeCampli WM, Pike NA, et al. A report of two hundred twenty cases of regional anesthesia in pediatric cardiac surgery. Anesth Analg 2000;90:1014-1019.

  78. Ralley FE. Neuraxial anesthesia is contraindicated in patients undergoing heparinization for surgery. Pro: neuraxial anesthesia should not be used in patients undergoing heparinization for surgery. J Cardiothorac Vasc Anesth 1996;10:957-960.

  79. Turnbull KW. Neuraxial anesthesia is contraindicated in patients undergoing heparinization for surgery. Con: neuraxial block is useful in patients undergoing heparinization for surgery. J Cardiothorac Vasc Anesth 1996;10:961-962.

  80. Anderson MB, Kwong KF, Furst AJ, et al. Thoracic epidural anesthesia for coronary bypass via left anterior thoracotomy in the conscious patient. Eur J Cardiothorac Surg 2001;20:415-417.

  81. Vanek T, Straka Z, Brucek P, et al. Thoracic epidural anesthesia for off-pump coronary artery bypass without intubation. Eur J Cardiothorac Surg 2001;20:858-860.

  82. Priestley MC, Cope L, Halliwell R, et al. Thoracic epidural anesthesia for cardiac surgery: the effects on tracheal intubation time and length of hospital stay. Anesth Analg 2002;94:275-282.

  83. Rosen DA, Hawkinberry DW, Rosen KR, et al. An epidural hematoma in an adolescent patient after cardiac surgery. Anesth Analg 2004;98:966-969.

  84. Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesth Analg 1997;84:1211-1221.

  85. Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest 2000;117:551-555.

  86. Liu SS, Block BM, Wu CL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: a metaanalysis. Anesthesiology 2004;101:153-161.

  87. Roediger L, Larbuisson R, Lamy M. New approaches and old controversies to postoperative pain control following cardiac surgery. Eur J Anaesthesiol 2006;23:539-550.

  88. Chaney MA. Cardiac surgery and intrathecal/epidural techniques: at the crossroads? Can J Anaesth 2005;52:783-788.

  89. Ruff RL, Dougherty JH Jr. Complications of lumbar puncture followed by anticoagulation. Stroke 1981;12:879-881.

  90. Brem SS, Hafler DA, Van Uitert RL, et al. Spinal subarachnoid hematoma: a hazard of lumbar puncture resulting in reversible paraplegia. N Engl J Med 1981;304:1020-1021.

  91. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994;79:1165-1177.

  92. Liu SS, Mulroy MF. Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med 1998;23:157-163.

  93. Ferraris VA, Ferraris SP, Joseph O, et al. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002;235:820-827.

  94. Denninger MH, Necciari J, Serre-Lacroix E, et al. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. Semin Thromb Hemost 1999;25:41-45.

  95. Beattie W, Badner N, Choi P. Epidural analgesia reduces postoperative myocardal infarction: a meta-analysis. Anesth Analg 2001;93:853-858.

  96. Konstantatos A, Silvers AJ, Miles PS. Analgesia best practice after cardiac surgery. Anesthesiol Clin 2008;26:591-602.

  97. Wu CL, Cohen SR, Richman JM, et al. Efficacy of postoperative patient-controlled and continuous infusion epidural analgesia versus intravenous patient– controlled analgesia with opioids: a meta-analysis. Anesthesiology 2005;103:1079-1088.

  98. Gravlee GP. Epidural analgesia and coronary artery bypass grafting: the controversy continues. J Cardiothoracic Vasc Anesth 2003;17:151-153.

  99. Casalino S, Mangia S, Stelian E, et al. High thoracic epidural anesthesia in cardiac surgery risk factors for arterial hypotension. Text Heart Inst J 2006;33:148-153.

  100. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010;35:64-101.

  101. Covarrubias-Gómez A, Guevara-López U, Gutiérrez-Salmerón C y cols. Epidemiología del dolor crónico en México. Rev Mex Anest 2010;33:207-213.

  102. Covarrubias-Gómez A, Guevara-López U, Lara-Solares A y cols. Características de los pacientes que acuden por primera vez a una clínica del dolor. Rev Med Inst Mex Seguro Soc 2008;46:467-472.

  103. Jackson PC, Morgan JM. Perioperative thomboprophylaxis in children: development of a guideline for management. Pediatr Anesth 2008;18:478-487.

  104. Carrillo ER, Márquez AP, Sosa-García J y cols. Guía de práctica clínica para la tromboprofilaxis en la Unidad de Terapia Intensiva. Rev Asoc Mex Med Crit y Ter Int 2011;25:227-254.

  105. Guzzetta NA, Miller BE. Principle of hemostasis in children: models and maduration. Pediatr Anesth 2011;21:3-9.

  106. Fung LS, Klockau C. Effects of age and weight-based dosing of enoxaparin on anti-factor Xa levels in pediatric patients. J Pediatr Pharmacol Ther 2010;15:119-125.

  107. Monagle P, Chan ACK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children. Antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e737S-e801S.

  108. Kenet G. Hemostasis and thrombosis in pediatric Patients: special issues and unique concerns. Semin Thromb Hemost 2011;37:721-722.

  109. Ignjatovic V, Mertyn E, Monagle P. the coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost 2011,37:723-729.

  110. Macartney C, Chan A. Thrombosis in children. Semin Thromb Hemost 2011;37:763-771.

  111. Bidlingmaier C, Kenet G, Kurnik K, et al. Safety and efficacy of low molecular weight heparins in children: A systematic review of the literature and meta-analysis of single-arm studies. Semin Thromb Hemost 2011;37:814-825.

  112. Chalmers E, Ganesen V, Liesner R, et al. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol 2001;154:196-207.

  113. Youn G. Old and new antithrombotics drugs in neonates and infants. Seminars in Fetal & Neonatal Medicine 2011;16:349-354.

  114. Kakkar AJ, Cohen AT, Tapson VF, et al. for the ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE Survey) findings in surgical patients. Ann Surg 2010;251:330-338.

  115. Trivkovic B. Anesthesia for hip replacement surgery. Med Glas Ljek Komore Zenicko-doboj Kantona 2012;9:143-151.

  116. Breivik H, Bang U. Nordic guidelines for neuraxial blocks in disturbed hemostasis from the Scandinavian Society of Anesthesiology and Intensive Care Medicine. Acta Anesthesiol Scand 2010;54:16-41.

  117. Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth 2011;107:96-106.

  118. Crowley M, Fischer B. Routine anaesthesia for joint replacement surgery. Anesth and Int Care Med 2008;7:377-380.

  119. Macfarlane AJR, Prasad GA, Chan VWS, et al. Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res 2009;467:2379-2402.

  120. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 9th ed. CHEST 2012;141:278S-325S.

  121. Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010;27:999-1015.

  122. Geerts WH, Berquist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Guidelines (8th edition). Chest 2008; 133:S381-453.

  123. National Institute for Health and Clinical Excellence. Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE guideline 2010;92:4-50.

  124. Ross N, Freeman N. Thromboprophylaxis part 2 anaesthesia tutorial of the week 244. ATOTW 2011:1-10.

  125. Eikelboom JW, Karthikeyan G, Fagel N, et al. American Association of Orthopedic Surgeons and American College of chest implications for clinicians and patients? Knee arthroplasty differ: what are the thromboembolism prevention in hip and physicians guidelines for venous. Chest 2009;135;513-520.

  126. Huisman MV, Quinlan DJ, Dahl OE, et al. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase iii multicenter randomized trials. Circ Cardiovasc Qual Outcomes 2010;3;652-660.

  127. Rosencher N, Bellamy L, Arnaout L. Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery? Arch Cardiovasc Dis 2009;102:327-333.

  128. Leng CL, Torillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth 2010;105:97-107.

  129. Agudelo JF, Morgan SJ, Smith WR. Venous thromboembolism in orthopedic trauma patients. Orthopedics 2005;28:1164.

  130. Toker S, Hak DJ, Morgan SJ. Deep vein thrombosis prophylaxis in trauma patients. Thrombosis 2011;2011:11. Article ID 505373. doi:10.1155/2011/505373.

  131. Ho KM, Burrell M, Rao S, et al. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. British Journal of Anaesthesia 2010;105:596-602.

  132. Paffrath T, Wafaisade A, Lefering R, et al. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury 2010:4197-101.

  133. Bahloul M, Chaari A, Dammak H, et al. Postraumatic pulmonary embolism in the Intensive Care Unit. Ann Thorac Med 2011;6:199-206.

  134. Selby R, Geerts W, Ofosu FA, et al. Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism. Thromb Res 2009;124:281-287.

  135. Tadel-Bringas GA, Santillana-Macedo MA, Romero-Cancio JA y cols. Aceptación y uso de medicina herbal en medicina familiar. Salud Pública Mex 1999;41:216-220.

  136. Covarrubias-Gómez A, Nuche-Cabrera E, Tellez-Isaias M. ¿Qué se autoadministra su paciente?: Interacciones farmacológicas de la medicina herbal. Rev Mex Anest 2005;28:32-42.

  137. American Society of Anesthesiologists: Herbal supplements and anesthesia 2010. Available in: http://www.lifelinetomodernmedicine.com/anesthesia-topics/herbal-supplements-and-anesthesia.aspx

  138. Lenox PH, Henderson CL. Herbal medicine use is frequent in ambulatory surgery patients in Vancouver Canada. Can J Anesth 2003;50:21-25.

  139. Adusimilli PS, Ben-Porat L, Pereira M, et al. The prevalence and predictors of herbal medicine use in surgical patients. J Am Coll Surg 2004;198:583-590.

  140. Kaye AD, Clarke RC, Sabar R, et al. Herbal medications: current trends in anesthesiology practice: A hospital survey. J Clin Anesth 2000;12:468-471.

  141. Izzo AA, Di Carlo G, Borelli F, et al. Cardiovascular pharmacotherapy and herbal medicine: the risk of drug interation. Int J Cardiol 2005;89:1-14.

  142. Llaun JV, Ferrandis R. New anticoagulants and regional anesthesia. Current Opinion in Anesthesiology 2009;22:661-666.

  143. Carrillo ER, Arias DR, Sánchez D. Inhibidores directos de trombina. Med Int Mex 2011;27:38-51.

  144. Gorgaten W, Vandermeulen E, Van Aken H. Regional anaesthesia and antithrombotic agents: recomendations of the Euopean Society on Anesthesiology (Guidelines). Eur J Anaesthesiol 2010;27:999-1015.

  145. Witker D, Prieto J. Nuevos anticoagulantes y antiagregantes plaquetarios de interés en cardiología. Cardiología Clínica 2008;24:30-35.

  146. Berge E, Sandercock PAG. Anticoagulants versus antiplatelet agents for acute ischemic stroke. 2011;4. DOI:10.1002/14651858.CD003242.

  147. Ordovás JP. Dabigatran and rivaroxaban, new oral anticoagulants for the treatment of venous thromboembolism. Farm Hosp 2009;33:123-124.

  148. Rodríguez J, Taboada M, García F, et al. Intraneural hematoma after nerve stimulation-guided femoral block in a patient with factor XI deficiency: case report. Journal of Clinical Anesthesia 2011;23:234-237.

  149. Lee CJ, Badhwar G, Ansell JE. Oral IIa inhibitors. Hematol Oncol Clin N Am 2010;24:739-753.

  150. Ageno W, Gallus A, Wittkowsky A. Antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicianss Evidence-Based Clinical Practice Guidelines. Chest 2012;41:e44S-88S.

  151. Schulman S, Kearon C. Dabigatran versus warfarina in the treatment of acute venous thromboembolism. N Engl J Med 2009;361:2342.

  152. Connolly SJ, Ezekowitz MD. Dabigratan versus warfarina in patients with atrial fibrillation. N Engl J Med 2009;361:1139.

  153. Dhillon S. Argatroban. A review of its use in the management of heparin-induced thrombocytopenia. Am J Cardiovasc Drugs 2009;9:261-282.

  154. García DA, Trevor P. Parenteral anticoagulants antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e24s-e43s.

  155. Alonso JJ, Curcio A, Graupner C y cols. Vigencia de los inhibidores de la glucoproteína IIb/IIIa en el tratamiento de los síndromes coronarios agudos ¿Bivalirudina o heparina asociada a inhibidores de la glucoproteína IIb/IIIa en el síndrome coronario agudo sin elevación del ST? Rev Esp Cardiol Supl 2011;11:20-26.

  156. Singelyn FJ, Verheyen CCPM, Piovella F. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter; the EXPERT Study. Anesth Analg 2007;105:1540-1547.

  157. Schindewolf, M, Scheuermann J, Kroll H, et al. Low allergenic potential with fondaparinux: results of a prospective investigation. Mayo Clin Proc 2010;85:913-919.

  158. Equinox investigators. Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis. Journal of Thrombosis and Haemostasis 2011;9(1):92-99.

  159. Ahrens I, Lip GY, Peter K. New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 2010;104:49-60.




2020     |     www.medigraphic.com